Harbour Investments »

Enlivex Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $15k 16k 0.93

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p 500 Etf Etf (IVV)
Capital Group Core Plus Income Etf Etf (CGCP)
State Street Spdr S&p 500 Etf Etf (SPY)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares S&p 500 Value Etf Etf (IVE)
Schwab Us Dividend Equity Etf Etf (SCHD)

View all positions for Harbour Investments

Top funds holding Enlivex Therapeutics

Diametric Capital
ARK Investment Management
Renaissance Technologies
Two Sigma Investments
UBS Group
Bank of America Corporation
Goldman Sachs Group
Morgan Stanley
Geode Capital Management
XTX Topco
Invesco
Citadel Advisors
Virtu Financial
Two Sigma Securities
Prosperity Consulting Group

View all funds holding Enlivex Therapeutics